Suppr超能文献

肾病理学中的半乳糖凝集素-3:不止是无辜旁观者

Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander.

作者信息

Desmedt Valérie, Desmedt Stéphanie, Delanghe Joris R, Speeckaert Reinhart, Speeckaert Marijn M

机构信息

Department of Nephrology, Ghent University Hospital, Ghent, Belgium.

出版信息

Am J Nephrol. 2016;43(5):305-17. doi: 10.1159/000446376. Epub 2016 May 12.

Abstract

BACKGROUND

Galectin-3 is a member of a closely related lectin family, which is detected in several vertebrate epithelial and myeloid cell types. This beta-galactoside-binding soluble protein plays an important role in multiple biological processes. Depending on its location, type of injury or site of damage, the effects by galectin-3 can be various and sometimes contrasting.

SUMMARY

In this review, we discuss the general characteristics and functions of galectin-3. More specifically, we focus on the role of galectin-3 in the onset and development of diabetic and non-diabetic nephropathies. Finally, the therapeutic potential of anti-galectin-3 inhibitors is discussed.

KEY MESSAGES

Due to its multifunctional character, galectin-3 plays a pivotal role in interstitial fibrosis and progression of chronic kidney disease. Inhibition of galectin-3 may be a promising therapeutic strategy to prevent end-stage renal disease.

摘要

背景

半乳糖凝集素-3是一个密切相关的凝集素家族的成员,在几种脊椎动物上皮细胞和髓样细胞类型中均可检测到。这种结合β-半乳糖苷的可溶性蛋白在多种生物学过程中发挥重要作用。根据其位置、损伤类型或损伤部位,半乳糖凝集素-3的作用可能多种多样,有时甚至相互矛盾。

总结

在本综述中,我们讨论了半乳糖凝集素-3的一般特征和功能。更具体地说,我们重点关注半乳糖凝集素-3在糖尿病和非糖尿病肾病的发生和发展中的作用。最后,讨论了抗半乳糖凝集素-3抑制剂的治疗潜力。

关键信息

由于其多功能特性,半乳糖凝集素-3在间质纤维化和慢性肾脏病进展中起关键作用。抑制半乳糖凝集素-3可能是预防终末期肾病的一种有前景的治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验